James Harrison

1.1k total citations
20 papers, 695 citations indexed

About

James Harrison is a scholar working on Immunology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, James Harrison has authored 20 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in James Harrison's work include Atherosclerosis and Cardiovascular Diseases (7 papers), Pain Mechanisms and Treatments (3 papers) and Immune Cell Function and Interaction (3 papers). James Harrison is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (7 papers), Pain Mechanisms and Treatments (3 papers) and Immune Cell Function and Interaction (3 papers). James Harrison collaborates with scholars based in United Kingdom, United States and France. James Harrison's co-authors include Ziad Mallat, Lauren Baker, Leanne Masters, Andrew P. Sage, Christoph J. Binder, Dimitrios Tsiantoulas, Deirdre Murphy, M. A. Ogryzlo, Céline Loinard and Nichola Figg and has published in prestigious journals such as Nature, Circulation and Immunity.

In The Last Decade

James Harrison

19 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Harrison United Kingdom 16 339 238 101 93 82 20 695
Carol Donovan United States 14 281 0.8× 350 1.5× 45 0.4× 60 0.6× 104 1.3× 20 996
Tiziana Adage Austria 13 151 0.4× 202 0.8× 88 0.9× 40 0.4× 70 0.9× 27 666
Marie‐Pierre Pruniaux France 15 146 0.4× 305 1.3× 190 1.9× 40 0.4× 63 0.8× 21 618
Dorothy Sears Worrall United States 8 226 0.7× 299 1.3× 165 1.6× 96 1.0× 35 0.4× 8 606
Cheng-Po Sung United States 13 120 0.4× 159 0.7× 114 1.1× 41 0.4× 84 1.0× 14 547
Simon P. Green Australia 8 279 0.8× 149 0.6× 147 1.5× 55 0.6× 31 0.4× 8 586
Christian Fork Germany 16 183 0.5× 347 1.5× 136 1.3× 43 0.5× 25 0.3× 21 782
M A Giembycz United Kingdom 20 240 0.7× 514 2.2× 527 5.2× 38 0.4× 98 1.2× 28 1.0k
Hyehun Choi United States 15 179 0.5× 266 1.1× 120 1.2× 43 0.5× 16 0.2× 25 512
Nadan Wang United States 16 108 0.3× 505 2.1× 96 1.0× 40 0.4× 98 1.2× 28 842

Countries citing papers authored by James Harrison

Since Specialization
Citations

This map shows the geographic impact of James Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Harrison more than expected).

Fields of papers citing papers by James Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Harrison. The network helps show where James Harrison may publish in the future.

Co-authorship network of co-authors of James Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of James Harrison. A scholar is included among the top collaborators of James Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Harrison. James Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ćorović, Andrej, Xin Zhao, Yuan Huang, et al.. (2023). Multimodality imaging and immunophenotyping of COVID-19 related myocardial injury (the MIIC-MI Study). European Heart Journal. 44(Supplement_2). 1 indexed citations
2.
Johansen, K., Dominic P. Golec, Bonnie Huang, et al.. (2022). A CRISPR screen targeting PI3K effectors identifies RASA3 as a negative regulator of LFA-1–mediated adhesion in T cells. Science Signaling. 15(743). eabl9169–eabl9169. 15 indexed citations
3.
Yu, Xianjun, Chen Xiao, Mamta Amrute‐Nayak, et al.. (2021). MARK4 controls ischaemic heart failure through microtubule detyrosination. Nature. 594(7864). 560–565. 61 indexed citations
4.
Yu, Xianjun, Stephen A. Newland, Tian Zhao, et al.. (2021). Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial Infarction. Journal of the American College of Cardiology. 78(11). 1127–1142. 34 indexed citations
5.
Lu, Yuning, Gemma Basatemur, Ian C. Scott, et al.. (2020). Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages. Immunity. 52(5). 782–793.e5. 35 indexed citations
6.
Nus, Meritxell, Gemma Basatemur, María Galán, et al.. (2020). NR4A1 Deletion in Marginal Zone B Cells Exacerbates Atherosclerosis in Mice—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 40(11). 2598–2604. 31 indexed citations
7.
Masters, Leanne, Dimitrios Tsiantoulas, Meritxell Nus, et al.. (2019). B Cell Fcγ Receptor IIb Modulates Atherosclerosis in Male and Female Mice by Controlling Adaptive Germinal Center and Innate B-1-Cell Responses. Arteriosclerosis Thrombosis and Vascular Biology. 39(7). 1379–1389. 18 indexed citations
8.
Clément, Marc, Juliette Raffort, Fabien Lareyre, et al.. (2019). Impaired Autophagy in CD11b + Dendritic Cells Expands CD4 + Regulatory T Cells and Limits Atherosclerosis in Mice. Circulation Research. 125(11). 1019–1034. 37 indexed citations
9.
Williams, Steven E., Nick Linton, James Harrison, et al.. (2017). Intra-Atrial Conduction Delay Revealed by Multisite Incremental Atrial Pacing is an Independent Marker of Remodeling in Human Atrial Fibrillation. JACC. Clinical electrophysiology. 3(9). 1006–1017. 19 indexed citations
10.
Sage, Andrew P., Deirdre Murphy, Pasquale Maffia, et al.. (2014). MHC Class II–Restricted Antigen Presentation by Plasmacytoid Dendritic Cells Drives Proatherogenic T Cell Immunity. Circulation. 130(16). 1363–1373. 71 indexed citations
11.
Chubb, Henry, James Harrison, Steven E. Williams, et al.. (2014). 65 * First in man: real-time magnetic resonance-guided ablation of typical right atrial flutter using active catheter tracking. EP Europace. 16(suppl 3). iii25–iii25. 4 indexed citations
12.
Gray, Kelly, Sheetal Kumar, Nichola Figg, et al.. (2014). Effects of DNA Damage in Smooth Muscle Cells in Atherosclerosis. Circulation Research. 116(5). 816–826. 81 indexed citations
13.
Sage, Andrew P., Dimitrios Tsiantoulas, Lauren Baker, et al.. (2012). BAFF Receptor Deficiency Reduces the Development of Atherosclerosis in Mice—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 32(7). 1573–1576. 125 indexed citations
14.
Sage, Andrew P., James Harrison, Lauren Baker, et al.. (2011). Abstract 9224: Depletion of Mature B cells by Deletion of BAFF Receptor Reduces Atherosclerosis in ldlr Knockout Mice. Circulation. 124(suppl_21).
15.
Hummel, Michele, Terri Cummons, Peimin Lu, et al.. (2010). Pain is a salient “stressor” that is mediated by corticotropin-releasing factor-1 receptors. Neuropharmacology. 59(3). 160–166. 39 indexed citations
16.
Vu, A. T., Puwen Zhang, Paige E. Mahaney, et al.. (2010). 1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as Potent and Selective Norepinephrine Reuptake Inhibitors. Journal of Medicinal Chemistry. 53(5). 2051–2062. 19 indexed citations
17.
Sullivan, Nicole R., Liza Leventhal, James Harrison, et al.. (2007). Pharmacological Characterization of the Muscarinic Agonist (3 R,4 R)-3-(3-Hexylsulfanyl-pyrazin-2-yloxy)-1-aza-bicyclo[2.2.1]heptane (WAY-132983) in in Vitro and in Vivo Models of Chronic Pain. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1294–1304. 27 indexed citations
18.
Ilyin, Victor I., James D. Pomonis, Garth T. Whiteside, et al.. (2006). Pharmacology of 2-[4-(4-Chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: A Potent, Broad-Spectrum State-Dependent Sodium Channel Blocker for Treating Pain States. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1083–1093. 27 indexed citations
19.
20.
Ogryzlo, M. A. & James Harrison. (1957). Evaluation of Uricosuric Agents in Chronic Gout. Annals of the Rheumatic Diseases. 16(4). 425–437. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carol Donovan Breakdown of academic impact, for papers by Tiziana Adage Breakdown of academic impact, for papers by Marie‐Pierre Pruniaux Breakdown of academic impact, for papers by Dorothy Sears Worrall Breakdown of academic impact, for papers by Cheng-Po Sung Breakdown of academic impact, for papers by Simon P. Green Breakdown of academic impact, for papers by Christian Fork Breakdown of academic impact, for papers by M A Giembycz Breakdown of academic impact, for papers by Hyehun Choi Breakdown of academic impact, for papers by Nadan Wang
Rankless by CCL
2026